CCL21 and systemic sclerosis: In the previously published ELISA1 cohort (15), serum levels of CCL21 were higher in SSc patients than healthy controls (0.49 ± 0.33ng/ml vs. 0.24 ± 0.08ng/ml, p<0.001) (Figure 4A, i).